75 related articles for article (PubMed ID: 15899806)
1. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis and tumor progression of MK-0429, an integrin αvβ
Nakagawa T; Ohta K; Naruse T; Sakuma M; Fukada S; Yamakado N; Akagi M; Sasaki K; Niwata C; Ono S; Aikawa T
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3281-3292. PubMed ID: 35713706
[TBL] [Abstract][Full Text] [Related]
3. Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.
D'Amico G; Robinson SD; Germain M; Reynolds LE; Thomas GJ; Elia G; Saunders G; Fruttiger M; Tybulewicz V; Mavria G; Hodivala-Dilke KM
PLoS One; 2010 Mar; 5(3):e9766. PubMed ID: 20339539
[TBL] [Abstract][Full Text] [Related]
4. Microfibril-Associated Glycoprotein-2 Promoted Fracture Healing via Integrin αvβ3/PTK2/AKT Signaling.
Chen Z; Zhao H; Meng L; Yu S; Liu Z; Xue J
Lab Invest; 2023 Jul; 103(7):100121. PubMed ID: 36934797
[TBL] [Abstract][Full Text] [Related]
5. Role of endothelial cell-selective adhesion molecule in hematogeneous metastasis.
Cangara HM; Ishida T; Hara T; Sun L; Toh R; Rikitake Y; Kundu RK; Quertermous T; Hirata K; Hayashi Y
Microvasc Res; 2010 Jul; 80(1):133-41. PubMed ID: 20153339
[TBL] [Abstract][Full Text] [Related]
6. Blockage of αvβ3 integrin in 3D culture of triple-negative breast cancer and endothelial cells inhibits migration and discourages endothelial-to-mesenchymal plasticity.
Casali BC; Baptista MP; Pachane BC; Cortez AA; Altei WF; Selistre-de-Araújo HS
Biochem Biophys Rep; 2024 Jul; 38():101686. PubMed ID: 38524278
[TBL] [Abstract][Full Text] [Related]
7. Integrin α3β1 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis.
Bae E; Huang P; Müller-Greven G; Hambardzumyan D; Sloan AE; Nowacki AS; Marko N; Carlin CR; Gladson CL
Nat Commun; 2022 Jul; 13(1):4268. PubMed ID: 35879332
[TBL] [Abstract][Full Text] [Related]
8. Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment.
Turaga RC; Satyanarayana G; Sharma M; Yang JJ; Wang S; Liu C; Li S; Yang H; Grossniklaus H; Farris AB; Gracia-Sancho J; Liu ZR
Commun Biol; 2021 Sep; 4(1):1087. PubMed ID: 34531529
[TBL] [Abstract][Full Text] [Related]
9. FS145, the first flea-derived disintegrin, inhibits angiogenesis through specifically binding integrin α
Lu W; Xiao Z; Liao H; Xie J; Gao Y; Xiong W; Zeng Q; Deng Z; Wu J; Chai J; Chen X; Xu X
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129289. PubMed ID: 38211910
[TBL] [Abstract][Full Text] [Related]
10. Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis.
Shi M; Wei Y; Guo R; Luo F
J Inflamm Res; 2024; 17():2285-2298. PubMed ID: 38645878
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
Palomeras S; Diaz-Lagares Á; Viñas G; Setien F; Ferreira HJ; Oliveras G; Crujeiras AB; Hernández A; Lum DH; Welm AL; Esteller M; Puig T
Breast Cancer Res; 2019 Jul; 21(1):79. PubMed ID: 31277676
[TBL] [Abstract][Full Text] [Related]
12. Generation of TGFBI knockout ABCG2+/ABCB5+ double-positive limbal epithelial stem cells by CRISPR/Cas9-mediated genome editing.
Kim EK; Kim S; Maeng YS
PLoS One; 2019; 14(2):e0211864. PubMed ID: 30753226
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Law JH; Bruce JP; Shi W; Renoult A; Chua MLK; Yip KW; Liu FF
Oncogenesis; 2018 May; 7(5):40. PubMed ID: 29795279
[TBL] [Abstract][Full Text] [Related]
14. Robust Therapeutic Efficacy of Matrix Metalloproteinase-2-Cleavable Fas-1-RGD Peptide Complex in Chronic Inflammatory Arthritis.
Nam EJ; Kang JH; Sa KH; Sung S; Park JY; Jo DG; Park JH; Kim IS; Kang YM
PLoS One; 2016; 11(10):e0164102. PubMed ID: 27741237
[TBL] [Abstract][Full Text] [Related]
15. BIGH3 modulates adhesion and migration of hematopoietic stem and progenitor cells.
Klamer SE; Kuijk CG; Hordijk PL; van der Schoot CE; von Lindern M; van Hennik PB; Voermans C
Cell Adh Migr; 2013; 7(5):434-49. PubMed ID: 24152593
[TBL] [Abstract][Full Text] [Related]
16. The role of TGFBI in mesothelioma and breast cancer: association with tumor suppression.
Li B; Wen G; Zhao Y; Tong J; Hei TK
BMC Cancer; 2012 Jun; 12():239. PubMed ID: 22695319
[TBL] [Abstract][Full Text] [Related]
17. Cross talk between engulfment receptors stabilin-2 and integrin αvβ5 orchestrates engulfment of phosphatidylserine-exposed erythrocytes.
Kim S; Park SY; Kim SY; Bae DJ; Pyo JH; Hong M; Kim IS
Mol Cell Biol; 2012 Jul; 32(14):2698-708. PubMed ID: 22566688
[TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.
Shin SH; Kim J; Heo SC; Kwon YW; Kim YM; Kim IS; Lee TG; Kim JH
Mol Cell Proteomics; 2012 Feb; 11(2):M111.012385. PubMed ID: 22159598
[TBL] [Abstract][Full Text] [Related]
19. Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.
Niland S; Eble JA
J Oncol; 2012; 2012():125278. PubMed ID: 21941547
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway.
Wen G; Hong M; Li B; Liao W; Cheng SK; Hu B; Calaf GM; Lu P; Partridge MA; Tong J; Hei TK
Int J Oncol; 2011 Oct; 39(4):1001-9. PubMed ID: 21701776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
